129 related articles for article (PubMed ID: 21960689)
1. Impact of EGFR genetic variants on glioma risk and patient outcome.
Costa BM; Viana-Pereira M; Fernandes R; Costa S; Linhares P; Vaz R; Pinheiro C; Lima J; Soares P; Silva A; Pardal F; Amorim J; Nabiço R; Almeida R; Alegria C; Pires MM; Pinheiro C; Carvalho E; Oliveira P; Lopes JM; Reis RM
Cancer Epidemiol Biomarkers Prev; 2011 Dec; 20(12):2610-7. PubMed ID: 21960689
[TBL] [Abstract][Full Text] [Related]
2. Association between functional EGF+61 polymorphism and glioma risk.
Costa BM; Ferreira P; Costa S; Canedo P; Oliveira P; Silva A; Pardal F; Suriano G; Machado JC; Lopes JM; Reis RM
Clin Cancer Res; 2007 May; 13(9):2621-6. PubMed ID: 17473192
[TBL] [Abstract][Full Text] [Related]
3. A functional common polymorphism in a Sp1 recognition site of the epidermal growth factor receptor gene promoter.
Liu W; Innocenti F; Wu MH; Desai AA; Dolan ME; Cook EH; Ratain MJ
Cancer Res; 2005 Jan; 65(1):46-53. PubMed ID: 15665278
[TBL] [Abstract][Full Text] [Related]
4. EGFR gene polymorphisms -216G>T and -191C>A are risk markers for gastric cancer in Mexican population.
Torres-Jasso JH; Marín ME; Santiago-Luna E; Leoner JC; Torres J; Magaña-Torres MT; Perea FJ; Ibarra B; Sánchez-López JY
Genet Mol Res; 2015 Mar; 14(1):1802-7. PubMed ID: 25867325
[TBL] [Abstract][Full Text] [Related]
5. CYP1A1*2A polymorphism as a predictor of clinical outcome in advanced lung cancer patients treated with EGFR-TKI and its combined effects with EGFR intron 1 (CA)n polymorphism.
Nie Q; Yang XN; An SJ; Zhang XC; Yang JJ; Zhong WZ; Liao RQ; Chen ZH; Su J; Xie Z; Wu YL
Eur J Cancer; 2011 Sep; 47(13):1962-70. PubMed ID: 21616658
[TBL] [Abstract][Full Text] [Related]
6. EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) POLYMORPHIC VARIATIONS (-216G/T & -191 C/A) POSE A HIGH RISK TO PATIENTS WITH MALIGNANT GLIOMA.
Zahoor W; Pandith AA; Nisar S; Qasim I; Surana M; Ganie FA; Manzoor U; Arif SH; Rasool SUA; Lateef A; Shah P; Bhat RA
Exp Oncol; 2023 Oct; 45(2):203-210. PubMed ID: 37824771
[TBL] [Abstract][Full Text] [Related]
7. Gender-related survival differences associated with EGFR polymorphisms in metastatic colon cancer.
Press OA; Zhang W; Gordon MA; Yang D; Lurje G; Iqbal S; El-Khoueiry A; Lenz HJ
Cancer Res; 2008 Apr; 68(8):3037-42. PubMed ID: 18413774
[TBL] [Abstract][Full Text] [Related]
8. Relationship of EGFR mutations, expression, amplification, and polymorphisms to epidermal growth factor receptor inhibitors in the NCI60 cell lines.
Liu W; Wu X; Zhang W; Montenegro RC; Fackenthal DL; Spitz JA; Huff LM; Innocenti F; Das S; Cook EH; Cox NJ; Bates SE; Ratain MJ
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6788-95. PubMed ID: 18006781
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms of glutathione S-transferases and the risk of adult brain tumors: a meta-analysis.
Lai R; Crevier L; Thabane L
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1784-90. PubMed ID: 16030117
[TBL] [Abstract][Full Text] [Related]
10. TP53 codon 72 polymorphism in susceptibility, overall survival, and adjuvant therapy response of gliomas.
Lima-Ramos V; Pacheco-Figueiredo L; Costa S; Pardal F; Silva A; Amorim J; Lopes JM; Reis RM
Cancer Genet Cytogenet; 2008 Jan; 180(1):14-9. PubMed ID: 18068527
[TBL] [Abstract][Full Text] [Related]
11. Exon 19 of EGFR mutation in relation to the CA-repeat polymorphism in intron 1.
Sueoka-Aragane N; Imai K; Komiya K; Sato A; Tomimasu R; Hisatomi T; Sakuragi T; Mitsuoka M; Hayashi S; Nakachi K; Sueoka E
Cancer Sci; 2008 Jun; 99(6):1180-7. PubMed ID: 18422739
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms of EGF 5'-UTR and NAT2 857G/A associated with glioma in a case control study of Malaysian patients.
Muthusamy KA; Lian LH; Vairavan N; Chua KH; Waran V
Genet Mol Res; 2012 Aug; 11(3):2939-45. PubMed ID: 22782629
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms in glutathione S-transferase mu and theta, N-acetyltransferase, and CYP1A1 and risk of gliomas.
Trizna Z; de Andrade M; Kyritsis AP; Briggs K; Levin VA; Bruner JM; Wei Q; Bondy ML
Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):553-5. PubMed ID: 9641501
[TBL] [Abstract][Full Text] [Related]
14. Allergy-related polymorphisms influence glioma status and serum IgE levels.
Wiemels JL; Wiencke JK; Kelsey KT; Moghadassi M; Rice T; Urayama KY; Miike R; Wrensch M
Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1229-35. PubMed ID: 17548690
[TBL] [Abstract][Full Text] [Related]
15. Prognostic stratification of patients with anaplastic gliomas according to genetic profile.
Dehais C; Laigle-Donadey F; Marie Y; Kujas M; Lejeune J; Benouaich-Amiel A; Pedretti M; Polivka M; Xuan KH; Thillet J; Delattre JY; Sanson M
Cancer; 2006 Oct; 107(8):1891-7. PubMed ID: 16986124
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor receptor gene polymorphisms predict pelvic recurrence in patients with rectal cancer treated with chemoradiation.
Zhang W; Park DJ; Lu B; Yang DY; Gordon M; Groshen S; Yun J; Press OA; Vallböhmer D; Rhodes K; Lenz HJ
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):600-5. PubMed ID: 15701846
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor receptor expression and gene amplification in high-grade non-brainstem gliomas of childhood.
Bredel M; Pollack IF; Hamilton RL; James CD
Clin Cancer Res; 1999 Jul; 5(7):1786-92. PubMed ID: 10430083
[TBL] [Abstract][Full Text] [Related]
18. Analysis of EGFR overexpression, EGFR gene amplification and the EGFRvIII mutation in Portuguese high-grade gliomas.
Viana-Pereira M; Lopes JM; Little S; Milanezi F; Basto D; Pardal F; Jones C; Reis RM
Anticancer Res; 2008; 28(2A):913-20. PubMed ID: 18507036
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor (EGFR) polymorphisms and survival in head and neck cancer patients.
Bandrés E; Barricarte R; Cantero C; Honorato B; Malumbres R; Zárate R; Alcalde J; García-Foncillas J
Oral Oncol; 2007 Aug; 43(7):713-9. PubMed ID: 17112774
[TBL] [Abstract][Full Text] [Related]
20. Serum IgE, tumor epidermal growth factor receptor expression, and inherited polymorphisms associated with glioma survival.
Wrensch M; Wiencke JK; Wiemels J; Miike R; Patoka J; Moghadassi M; McMillan A; Kelsey KT; Aldape K; Lamborn KR; Parsa AT; Sison JD; Prados MD
Cancer Res; 2006 Apr; 66(8):4531-41. PubMed ID: 16618782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
